Insulin Glargine-Yfgn
4 NDCs across 1 manufacturer|2 Generic,2 Brand
Insulin Glargine-Yfgn is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $102 million on Insulin Glargine-Yfgn across 586,000 claims for 229,000 beneficiaries.
Insulin Glargine-Yfgn is available as 4 NDCs from 1 manufacturer (2 generic, 2 brand), with NADAC prices from $5.92 to $26.07 per ML — the most expensive product costs about 4.4× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
2G / 2B
Manufacturers
1
competing in market
Price Spread
$5.92 – $26.07
per ML
7d Activity
avg +0.1% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Biocon Biologics Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Insulin Analog class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing INSULIN GLARGINE-YFGN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SEMGLEE (YFGN) 100 UNIT/ML VL | $26.0674 per ML | +0.34% |
SEMGLEE (YFGN) 100 UNIT/ML PEN | $25.7546 per ML | -0.06% |
INSULIN GLARGINE-YFGN U100 VL | $6.0811 per ML | -0.09% |
INSULIN GLARGINE-YFGN U100 PEN | $5.9249 per ML | -0.01% |
Frequently Asked Questions
What is Insulin Glargine-Yfgn used to treat?
Insulin Glargine-Yfgn is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Insulin Glargine-Yfgn?
In 2024, Medicare Part D spent $102 million on Insulin Glargine-Yfgn across 586,000 claims for 229,000 beneficiaries.
How many Insulin Glargine-Yfgn products are on the market?
The Insulin Glargine-Yfgn drug market contains 4 NDCs from 1 manufacturer — 2 generic and 2 brand products.
What is the price range for Insulin Glargine-Yfgn?
NADAC reference prices for Insulin Glargine-Yfgn range from $5.9249 to $26.0674 per ML — the most expensive product costs about 4.4× the cheapest.
Is generic Insulin Glargine-Yfgn cheaper than brand?
The average generic NADAC for Insulin Glargine-Yfgn is $6.0030 per ML, versus $25.9110 for brand-labeled products — brand versions average about 4.3× the generic price.
Which manufacturers make Insulin Glargine-Yfgn?
1 manufacturer lists Insulin Glargine-Yfgn in NADAC. Ranked by number of NDCs, the largest are Biocon Biologics Inc. (4).
How has the price of Insulin Glargine-Yfgn changed recently?
Over the past 7 days, 1 Insulin Glargine-Yfgn NDC rose and 3 fell, with a market-wide average change of +0.1%.